Sign Up to like & get recommendations! 1
Published in 2021 at "JAMA internal medicine"
DOI: 10.1001/jamainternmed.2021.3942
Abstract: Importance In the US, most postmarket medical device safety data are obtained through adverse event reports that are submitted to the US Food and Drug Administration (FDA)'s Manufacturer and User Facility Device Experience (MAUDE) database.… read more here.
Sign Up to like & get recommendations! 1
Published in 2019 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2019.9249
Abstract: Key Points Question What is the postmarketing safety profile of sipuleucel-T in the United States? Findings The US Food and Drug Administration’s Adverse Event Reporting System received 3216 reports for sipuleucel-T from 2010 through 2017.… read more here.
Sign Up to like & get recommendations! 0
Published in 2024 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2024.42936
Abstract: This cohort study examines whether hospital COVID-19 burden was associated with rates of in-hospital adverse events among Medicare patients during the COVID-19 pandemic. read more here.
Sign Up to like & get recommendations! 0
Published in 2025 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2025.12455
Abstract: This systematic review examines whether adverse event costs in cost-effectiveness analyses of anticancer drugs accurately reflect costs reported in claims-based studies. read more here.
Sign Up to like & get recommendations! 0
Published in 2018 at "JAMA Pediatrics"
DOI: 10.1001/jamapediatrics.2018.0830
Abstract: Importance It is not clear whether adherence to preprocedural fasting guidelines prevent pulmonary aspiration and associated adverse outcomes during emergency department (ED) sedation of children. Objective To examine the association between preprocedural fasting duration and… read more here.
Sign Up to like & get recommendations! 0
Published in 2025 at "Brain and Behavior"
DOI: 10.1002/brb3.70467
Abstract: The effect of antipsychotic drugs on epilepsy is controversial, and we performed Food and Drug Administration Adverse Event Reporting System (FAERS) data mining and Mendelian Randomization (MR) analyses to clarify the effects of target genes… read more here.
Sign Up to like & get recommendations! 0
Published in 2024 at "Cancer Medicine"
DOI: 10.1002/cam4.70548
Abstract: Emerging evidence suggests potential cardiovascular toxicities from oral endocrine therapies (ETs); however, results are conflicting. This study comprehensively examined adverse reactions of ETs and investigated cardiovascular and metabolic safety signals within the FDA Adverse Event… read more here.
Sign Up to like & get recommendations! 1
Published in 2020 at "Clinical Pharmacology and Therapeutics"
DOI: 10.1002/cpt.2074
Abstract: We improved a previous pharmacological target adverse‐event (TAE) profile model to predict adverse events (AEs) on US Food and Drug Administration (FDA) drug labels at the time of approval. The new model uses more drugs… read more here.
Sign Up to like & get recommendations! 1
Published in 2023 at "Pharmacoepidemiology and drug safety"
DOI: 10.1002/pds.5610
Abstract: BACKGROUND The large-scale COVID-19 vaccination campaigns in 2021 and 2022 led to a rapid increase in numbers of received adverse event reports in spontaneous reporting systems. As background incidences of naturally occurring medical events became… read more here.
Sign Up to like & get recommendations! 0
Published in 2024 at "Pharmacoepidemiology and Drug Safety"
DOI: 10.1002/pds.70030
Abstract: Upadacitinib, a Janus kinase (JAK) inhibitor, has been approved by the FDA to treat various autoimmune conditions. This study assessed its adverse events by analyzing reports from the FDA Adverse Event Reporting System (FAERS). read more here.
Sign Up to like & get recommendations! 0
Published in 2025 at "Pharmacoepidemiology and Drug Safety"
DOI: 10.1002/pds.70100
Abstract: The use of real‐world data is increasing to examine immune‐related adverse event (irAE) incidence and risk factors in immune checkpoint inhibitor (ICI) users. We aimed to validate five case definition algorithms for irAE in a… read more here.